AG-73305
Diabetic Macular Edema, neovascular AMD, other retinal diseases
Phase 2aActive
Key Facts
Indication
Diabetic Macular Edema, neovascular AMD, other retinal diseases
Phase
Phase 2a
Status
Active
Company
About Allgenesis Biotherapeutics
Taiwan biotech developing bispecific ocular biologics for DME, dry eye and AMD.
View full company profile